Ovariectomy increases mitogens and platelet-induced proliferation of arterial smooth muscle

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Bracamonte, M P ^a   Rud, K S ^a   Owen, Whyte G ^a   Miller, V M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Estrogen; Hormone; Megakaryocytes; Platelet derived growth factor; Transforming growth factor

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; CELL COUNT; CELL CULTURE; CELL LYSATE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SWINE; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0036352540     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00201.2002     Document Type: Article

References (45)

1. Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1
2. Pathophysiology of vascular endothelium and circulating platelets: Implications for coronary revascularization and treatment
3. Role of red blood cells in thrombosis
4. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women
5. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women
6. Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries
7. Estrogen and coronary heart disease in women
8. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis
9. The megakaryocyte platelet system and vascular disease
10. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
11. Platelet-derived growth factor regulates vascular smooth muscle cell proliferation by inducing cationic amino acid transporter gene expression
12. Physical and chemical effects of red cells in the shearinduced aggregation of human platelets
13. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor
14. Homocystineinduced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis
15. Platelet-derived growth factor (PDGF): Actions and mechanisms in vascular smooth muscle
16. Effects of platelet-contained growth factors (PDGF, EGF, IGF-1, and TGF-β) on DNA synthesis in porcine aortic smooth muscle cells in culture
17. Reticulated platelets following acute blood loss
18. Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets
19. Human megakaryocytes and platelets contain the estrogen receptor β and androgen receptor (AR): Testosterone regulates AR expression
20. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro
21. Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming growth factor-beta(1) and platelet-derived growth factor(AB)
22. Novel risk factors for atherosclerosis
23. TGF-betas and TGF-beta receptors in atherosclerosis
24. The protective effects of estrogen on the cardiovascular system
25. Transforming growth factorbeta inhibits human vascular smooth muscle cell growth and migration
26. Gender differences and endothelium- and platelet-derived factors in the coronary circulation
27. Differential response in cell proliferation to beta estradiol in coronary artery vascular smooth muscle cells obtained from mature female versus male animals
28. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
29. Correlation between plasma levels of growth factor and von Willebrand factor
30. Increased platelet derived mitogenic activity in plasma of young patients with coronary atherosclerosis
31. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
32. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries
33. 1 cell cycle arrest
34. The pathogenesis of atherosclerosis - An update
35. Platelet-derived growth factor
36. The pathogenesis of atherosclerosis
37. Mechanisms initiating platelet thrombus formation
38. The good smooth muscle cells in atherosclerosis
39. Effects of 17beta-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro
40. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment
41. Platelet-derived serotonin, the endothelium, and cardiovascular disease
42. Endothelial dysfunction and atherosclerosis
43. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells
44. Mechanical influences on vascular smooth muscle cell function
45. Platelet-derived growth factor stimulates low density lipoprotein receptor activity in cultured human fibroblasts